Post-earnings recap
Reported
Wed, Mar 2, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Teladoc Health's earnings report showed a loss per share that was slightly better than expected, but the lack of revenue information and guidance contributed to a negative stock reaction, with shares falling by 2.11%. Investors may be cautious due to the absence of additional insights from management.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.39 | N/A | +5.34% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.